GENZYME CORPORATION GENZ (NASDAQ) $ 72.10 Change: -1.07 -1.48% | Volume: 3,410,733
Sponsored by Click here!

GENZYME- GENERAL

Company Information

Ticker Symbol: GENZ
Exchange: NASD
Contact Info: 500 Kendall Street Cambridge MA 02142 617 252-7500
CEO/President: Henri A. Termeer
Industry: Medical - Biomedical / Standard Industry Code: 2836
Description: Genzyme Corporation is a global biotechnology company dedicated to making a major positive impact on the lives of people with serious diseases. The company\'s broad product portfolio is focused on rare genetic disorders, renal disease, and osteoarthritis, and includes an industry-leading array of diagnostic products and services. Genzyme\'s commitment to innovation continues today with research into novel approaches to cancer, heart disease, and other areas of unmet medical need.

Share Information

Shares Outstanding: 267,310 (000) Market Value: 17,352,300 ($000)
Percentage of Inst.Shareholders: 86.92% Number of Inst.Shareholders: 2.80%
Last Quarter Sales: 1171.13 ($Mil.) Last Quarter Net Income: 69.56 ($Mil.)
Last Quarter EPS: 0.81 P/E Ratio: 19
Most Recent Earnings: 0.98 on 07/23/08 Earnings Per Share: 1.63
Most Recent Split: 2-1 on 06/04/01 Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement

Top Competitors

AMGEN +0.50 53.80
GILEAD SCIENCES -10.20 42.65
GENENTECH INC +6.50 81.18
CELGENE CP -10.00 61.46
BIOGEN IDEC INC -32.40 47.13